Please ensure Javascript is enabled for purposes of website accessibility

Curaleaf Posts 22% Revenue Gain in Q4, Announces Acquisition

By Eric Volkman - Mar 24, 2020 at 5:59PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's bottom line loss was deeper than expected, however.

Curaleaf (CURLF -3.89%) had a busy day on Tuesday. After market hours, the marijuana company unveiled its fourth quarter of fiscal 2019 results, while earlier it announced an acquisition and updated investors on its business in the wake of the SARS-CoV-2 coronavirus outbreak.

For the quarter, the company's total revenue came in at nearly $75.5 million. That was 22% higher on a quarter-over-quarter basis, and more than double the fourth quarter 2018 result. Net loss deepened, however, to almost $26.6 million, from the third quarter shortfall of $6.8 million and the year-ago loss of $11.2 million.

Curaleaf's latest net loss shook out to $0.06 per share; according to data compiled by The Wall Street Journal, on average analysts were expecting only a $0.02 per share deficit. 

Marijuana leaf atop a 100 dollar bill.

Image source: Getty Images.

Separately, the company announced that it is purchasing three Arrow Alternative Care dispensaries in Connecticut. The three are among only 18 dispensaries in the state, all of which sell only medical marijuana, as the recreational form of the drug technically remains illegal there.

The three stores will sell Curaleaf product, and presumably be supplied by a cultivation facility the company operates near the capital city of Hartford.

Curaleaf disclosed neither the price nor the terms of the Arrow Alternative Care deal.

Finally, the cannabis company issued an update on its operations in the wake of the pandemic. It said it has obtained an Essential Services Designation in numerous markets where it operates, allowing its dispensaries to stay open in Arizona, Florida, Maine, Maryland, Massachusetts (only for medical marijuana), New Jersey, New York, and Oregon. It is boosting sanitation and hygiene measures, and maintaining social distancing principles.

Curaleaf's stock well outpaced Tuesday's broader stock market gains, rising by almost 25% on the day. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$5.07 (-3.89%) $0.20

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
319%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.